14 completed, 1 not yet recruiting, 1 terminated. 16 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 14, Not yet recruiting 1, Terminated 1 |
Follow Actinic Keratoses: new trials by email Literature Review of Actinic Keratoses trials Research Report on Actinic Keratoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead Cryotherapy + Tirbanibulin - Keratosis, Actinic Keratoses | Phase 3 | Not yet recruiting | University Hospital, Lille | 59 | 2026-11-30 | 2026-05-22 |
| Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp BF-200 ALA and red light LED lamp, Vehicle and red light LED lamp - Actinic Keratoses | Phase 3 | Completed | Biofrontera Inc. | 172 | 2022-12-12 | 2026-08-21 |
| Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis Test Product (A): Fluorouracil Cream, 5% topical cream, Reference Product (B): Fluorouracil 5% Topical Cream of Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., Placebo Product (C): Test vehicle cream for fluorouracil 5% of Encube Ethicals Pvt. Ltd., India - Actinic Keratoses | Phase 3 | Completed | Encube Ethicals Pvt. Ltd. | 458 | 2022-03-01 | 2023-03-14 |
| Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face MAL 16.8% cream, MAL Vehicle Cream - Actinic Keratoses | Phase 3 | Completed | Galderma R&D | 557 | 2019-09-30 | 2022-04-01 |
| Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis Diclofenac Sodium Gel, Solaraze 3% Topical Gel, Placebo - Actinic Keratoses | Phase 3 | Completed | Encube Ethicals Pvt. Ltd. | 655 | 2018-01-12 | 2019-02-01 |
| A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp Placebo, KX2-391 Ointment 1% - Actinic Keratoses | Phase 3 | Completed | Almirall, S.A. | 351 | 2017-09-18 | 2021-04-13 |
| Actinic Keratoses Treatment With Metvix® in Combination With Light Metvix®, Photodynamic Therapy Blue light, Photodynamic Therapy Daylight - Actinic Keratoses | Phase 3 | Completed | University Hospital, Limoges | 26 | 2015-03-25 | 2025-07-29 |
| Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses NDL-PDT, c-PDT, placebo c-PDT - Actinic Keratoses | Phase 3 | Completed | Galderma R&D | 131 | 2013-07-01 | 2021-02-18 |
| Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses Metvix and natural daylight PDT, Metvix and conventional PDT - Actinic Keratoses | Phase 3 | Completed | Galderma R&D | 100 | 2012-03-01 | 2021-02-18 |
| Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients MD-3511356, Standard Sun Protection Measures - Actinic Keratoses, Squamous Cell Carcinomas | Phase 3 | Terminated | Spirig Pharma Ltd. | 244 | 2010-11-01 | 2016-01-08 |
| Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo Brand Carac, Generic 0.5% 5-fluorouracil cream, Placebo cream - Actinic Keratoses | Phase 3 | Completed | Spear Pharmaceuticals | 377 | 2010-09-01 | 2014-10-20 |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses | Phase 3 | Completed | Peplin | 203 | 2009-07-01 | 2015-03-06 |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses | Phase 3 | Completed | Peplin | 255 | 2008-09-01 | 2015-03-06 |
| Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis imiquimod, Aldara™, Vehicle Cream - Actinic Keratoses | Phase 3 | Completed | Actavis Inc. | 462 | 2008-05-01 | 2020-09-04 |
| Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs) imiquimod cream, Placebo - Actinic Keratoses | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 479 | 2008-01-01 | 2010-06-29 |
| Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses imiquimod - Actinic Keratoses | Phase 3 | Completed | University of British Columbia | 20 | 2005-02-01 | 2006-05-09 |
Keratosis, Actinic (16) · Carcinoma, Squamous Cell (2) · Keratosis (2) · Precancerous Conditions (2) · Skin Diseases (2) · Neoplasms (1)
Skin and Connective Tissue Diseases (16) · Neoplasms (15) · Keratosis (14) · Precancerous Conditions (14) · Skin Diseases (14) · Carcinoma (2) · Neoplasms by Histologic Type (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Squamous Cell (2)
Gels (3) · 3-ingenyl angelate (2) · Fluorouracil (2) · Imiquimod (2) · methyl 5-aminolevulinate (2) · BF-200 ALA (1) · Cryotherapy (1) · Diclofenac (1) · Drugs, Generic (1) · Photochemotherapy (1) · tirbanibulin (1)
Galderma R&D (3) · Encube Ethicals Pvt. Ltd. (2) · Peplin (2) · Actavis Inc. (1) · Almirall, S.A. (1) · Biofrontera Inc. (1) · Graceway Pharmaceuticals, LLC (1) · Spear Pharmaceuticals (1) · Spirig Pharma Ltd. (1) · University Hospital, Lille (1) · University Hospital, Limoges (1) · University of British Columbia (1)
United States (9) · France (3) · Australia (2) · Germany (2) · Netherlands (2) · Austria (1) · Canada (1) · Czechia (1) · Ireland (1) · Puerto Rico (1) · Spain (1) · Sweden (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Bibiana Perez Garcia, MD (1) · Christine M. Winslow, Ph.D. (1) · Claas Ulrich, MD (1) · Ingrid Synnerstad, PhD, MD (1) · Jane Fang, MD (1) · Jason K Rivers, M.D. (1) · Melanie Appell, M.D. (1) · Nathalie Zeitouni, MD (1) · Nicole Basset Seguin, PhD, MD (1) · Rianne Gerritsen, PhD, MD (1) · Rolf-Markus Sziemies, PhD, MD (1) · Sharon F Levy, MD (1) · Stephen Shumack (1)